Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 12.8B | 11.4B | 10.4B | 10.3B |
| Cost of revenue | 6.2B | 5.6B | 5.0B | 5.2B |
| Gross profit | 6.6B | 5.8B | 5.4B | 5.1B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 2.8B | 2.5B | 2.2B | 2.2B |
| Operating income | 1.7B | 1.4B | 1.2B | 904M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 58M | 76M | 56M | 58M |
| Other income expense | — | — | — | — |
| Pretax income | 1.8B | 1.5B | 1.3B | 999M |
| Tax provision | 602M | 327M | 336M | 292M |
| Net income | 1.4B | 1.2B | 967M | 656M |
| Basic EPS | — | 14.8 | 12.1 | 8.2 |
| Diluted EPS | — | 14.8 | 12.1 | 8.2 |
| Basic average shares | — | 79.4M | 79.4M | 79.4M |
| Diluted average shares | — | 79.4M | 79.4M | 79.4M |
| EBITDA | 2.2B | 1.8B | 1.6B | 1.3B |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -7M | -13M | -10M | -5M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |